Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Carlota Arenillas"'
Autor:
Ariana Huebner, James R. M. Black, Francesca Sarno, Roberto Pazo, Ignacio Juez, Laura Medina, Rocio Garcia-Carbonero, Carmen Guillén, Jaime Feliú, Carolina Alonso, Carlota Arenillas, Ana Belén Moreno-Cárdenas, Helena Verdaguer, Teresa Macarulla, Manuel Hidalgo, Nicholas McGranahan, Rodrigo A. Toledo
Publikováno v:
Genome Medicine, Vol 15, Iss 1, Pp 1-15 (2023)
Abstract Background Liquid biopsies and the dynamic tracking of somatic mutations within circulating tumour DNA (ctDNA) can provide insight into the dynamics of cancer evolution and the intra-tumour heterogeneity that fuels treatment resistance. Howe
Externí odkaz:
https://doaj.org/article/21716a2b02ec46eb8dbe1a817c4a0bab
Autor:
Rodrigo A Toledo, Camilo Jimenez, Gustavo Armaiz-Pena, Carlota Arenillas, Jaume Capdevila, Patricia L M Dahia
Publikováno v:
Endocr Rev
Tumors driven by deficiency of the VHL gene product, which is involved in degradation of the hypoxia-inducible factor subunit 2 alpha (HIF2α), are natural candidates for targeted inhibition of this pathway. Belzutifan, a highly specific and well-tol
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::40498532fd48a0c27873eccb48cfec46
https://doi.org/10.1210/endrev/bnac025
https://doi.org/10.1210/endrev/bnac025
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Elena Elez, Javier Ros, Jose Fernández, Guillermo Villacampa, Ana Belén Moreno-Cárdenas, Carlota Arenillas, Kinga Bernatowicz, Raquel Comas, Shanshan Li, David Philip Kodack, Roberta Fasani, Ariadna Garcia, Javier Gonzalo-Ruiz, Alejandro Piris-Gimenez, Paolo Nuciforo, Grainne Kerr, Rossana Intini, Aldo Montagna, Marco Maria Germani, Giovanni Randon, Ana Vivancos, Ron Smits, Diana Graus, Raquel Perez-Lopez, Chiara Cremolini, Sara Lonardi, Filippo Pietrantonio, Rodrigo Dienstmann, Josep Tabernero, Rodrigo A. Toledo
Publikováno v:
Scientia
Nature Medicine, 28(10), 2162-2170. Nature Publishing Group
Nature Medicine, 28(10), 2162-2170. Nature Publishing Group
Colorectal cancer; Predictive markers; Tumour biomarkers Cáncer colorrectal; Marcadores predictivos; Biomarcadores tumorales Càncer colorrectal; Marcadors predictius; Biomarcadors tumorals Anti-BRAF/EGFR therapy was recently approved for the treatm
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::da1cfcc9244c422b74e6bbcfe10d9f95
https://hdl.handle.net/11351/8672
https://hdl.handle.net/11351/8672
Autor:
Elena, Elez, Javier, Ros, Jose, Fernández, Guillermo, Villacampa, Ana Belén, Moreno-Cárdenas, Carlota, Arenillas, Kinga, Bernatowicz, Raquel, Comas, Shanshan, Li, David Philip, Kodack, Roberta, Fasani, Ariadna, Garcia, Javier, Gonzalo-Ruiz, Alejandro, Piris-Gimenez, Paolo, Nuciforo, Grainne, Kerr, Rossana, Intini, Aldo, Montagna, Marco Maria, Germani, Giovanni, Randon, Ana, Vivancos, Ron, Smits, Diana, Graus, Raquel, Perez-Lopez, Chiara, Cremolini, Sara, Lonardi, Filippo, Pietrantonio, Rodrigo, Dienstmann, Josep, Tabernero, Rodrigo A, Toledo
Publikováno v:
Nature medicine. 28(10)
Anti-BRAF/EGFR therapy was recently approved for the treatment of metastatic BRAFsupV600E/supcolorectal cancer (mCRCsupBRAF-V600E/sup). However, a large fraction of patients do not respond, underscoring the need to identify molecular determinants of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::f04136c084a308bf8c9f9b942f7330c0
https://pubmed.ncbi.nlm.nih.gov/36097219
https://pubmed.ncbi.nlm.nih.gov/36097219
Autor:
Omar Saavedra Santa Gadea, Elena Elez, R. Berché, Cristina Saura, Maria del Mar Villar, Honey Kumar Oberoi, Ignacio Matos, Vladimir Galvao, Carlota Arenillas, Ana Maria Martin Moreno, Ana Oaknin, Guzman Alonso, Enriqueta Felip, Josep Tabernero, Rodrigo A. Toledo, Eva Muñoz-Couselo, Natassia Ann Wornham, Irene Brana, Elena Garralda, Javier Ros
Publikováno v:
Journal of Clinical Oncology. 39:2542-2542
2542 Background: Detection of ctDNA is a promising tool for managing pts in oncology. Most methods require whole-genome sequencing of tumor samples followed by the design of personalized panels for tracking purposes. In this work, we evaluated the pr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::24e88e01031d48e67e849bf919bc972f
https://doi.org/10.1200/jco.2021.39.15_suppl.2542
https://doi.org/10.1200/jco.2021.39.15_suppl.2542